Nitrous Oxide for Aggression
Trial Summary
What is the purpose of this trial?
This trial tests if inhaling nitrous oxide can help normalize brain function in people with impulsive aggression. Participants with and without aggressive tendencies will inhale the gas and undergo brain scans to see if it improves their brain activity. The goal is to find a potential treatment for those with Intermittent Explosive Disorder. Nitrous oxide has been shown to reduce involuntary movements in cerebral palsy patients, indicating its potential to affect brain function.
Will I have to stop taking my current medications?
The trial requires participants to be free of antipsychotic medication for two weeks before joining. However, if you are taking SSRIs, SNRIs, or mood stabilizers, you can continue using them as long as you still experience impulsive aggressive behaviors.
What data supports the effectiveness of the drug nitrous oxide for treating aggression?
Nitrous oxide is known for its anesthetic and pain-relieving properties, making it useful in various medical settings. Its ability to be safely administered by trained professionals and even self-administered by patients suggests it could have potential in managing conditions like aggression, although specific studies on aggression are not mentioned.12345
Is nitrous oxide generally safe for human use?
Nitrous oxide is generally considered safe when used in medical settings, like dentistry, for its anesthetic and anti-anxiety effects. However, heavy or prolonged use can lead to vitamin B12 deficiency, causing nerve damage and blood problems. Recreational use can also lead to accidents and, in rare cases, serious health issues.36789
How is nitrous oxide different from other drugs for treating aggression?
Nitrous oxide is unique because it is traditionally used as an anesthetic and for its calming effects in dentistry, but it is now being explored for its potential to treat psychiatric conditions like aggression at lower, non-anesthetic doses. This approach is novel compared to standard treatments, which typically involve medications like antipsychotics or mood stabilizers.13101112
Research Team
Emil Coccaro, Dr
Principal Investigator
Ohio State University
Eligibility Criteria
This trial is for adults aged 21-55 with Intermittent Explosive Disorder (IED) and high aggression scores, but no major psychiatric disorders like psychosis or bipolar disorder, nor current severe substance abuse. Healthy participants without any psychiatric conditions and low aggression can also join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 60 minute inhalation session with 50% Nitrous Oxide or room air, followed by an fMRI scan 24 hours later
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Nitrous Oxide
- Room Air
Nitrous Oxide is already approved in European Union, United States, Canada for the following indications:
- Anesthesia
- Pain relief
- Hypoxic respiratory failure in neonates
- Anesthesia
- Pain relief
- Hypoxic respiratory failure in neonates
- Anesthesia
- Pain relief
- Hypoxic respiratory failure in neonates
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator